{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 5729"}, "official-title": {"#tail": "\n\t", "#text": "To expand the program of priority review to encourage treatments for tropical diseases."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20141118", "#text": "November 18, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for herself, ", "#text": "Mrs. Blackburn", "@name-id": "B001243"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Gene Green of Texas", "@name-id": "G000410"}, {"#tail": ", ", "#text": "Mr. Butterfield", "@name-id": "B001251"}, {"#tail": ", and ", "#text": "Mr. McCaul", "@name-id": "M001157"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Fleischmann", "@name-id": "F000459"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H83A5A645A4114251BB71454BCA64089E", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Adding Ebola to the FDA Priority Review Voucher Program Act", "@value": "Adding Ebola to the FDA Priority Review Voucher Program Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H39D3C0A6535842F4A8A89E736E9A418C"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 524 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:524"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 360n", "@value": "usc/21/360n"}, "@parsable-cite": "usc/21/360n", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Priority review to encourage treatments for tropical diseases"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "in subsection (a)(3)\u2014"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "#text": "\n        ", "@id": "H08CCEF36EE704B25A1CB45B31F5CB4EE", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "by redesignating subparagraph (Q) as subparagraph (R);"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H01D79E5E527646BA9146EBFBA9707AAE", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by inserting after subparagraph (P) the following:"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "; and"}, "#tail": "\n\t\t\t\t", "@id": "HD2EB684FB41746BD9B6F3E9E68B218F7", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "subparagraph": {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "Filoviruses."}, "enum": {"#tail": "\n              ", "#text": "(Q)"}, "@id": "H533C2007E0C74D388DB4AF280B2410A4", "#text": "\n              "}}, "#text": "\n          ", "@id": "HAF65F12CA5DF461D9A189B9A948F0DF3"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "regulation by"}, {"#tail": "; and", "#text": "order of"}], "#text": "in subparagraph (R), as so redesignated, by striking "}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "H2F5EC8D0542B4398953CD6794A856EFB", "#text": "\n          "}]}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "in subsection (b)\u2014"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "#text": "\n        ", "@id": "HB36358164A0F4E28B3EA729CFEF44D7F", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " after the period at the end; and", "#text": "There is no limit on the number of times a priority review voucher may be transferred before such\n\t\t\t voucher is used."}, "#text": "in paragraph (2), by adding "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "HCFC3147A598B41A3BDEEB90CD94CDB2A", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "365 days"}, {"#tail": ".", "#text": "90 days"}], "#text": "in paragraph (4), by striking "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H57973A1F624347CF87FA3A4EB8AE3319", "#text": "\n          "}]}], "#text": "\n      ", "@id": "H1CD61A4E39284BC99B0EE669AE1DC345"}], "#text": "\n\t\t", "@id": "HA1A97D5DCDC14BCC9262117C7A5D2AF5"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-11-18"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 5729 IH: Adding Ebola to the FDA Priority Review Voucher Program Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}